Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Vienna AI Firm Turns European Heart Patient Research Into 7 AI Personas
EIN Presswire
OptimusFlow Consulting developed seven AI patient personas for HCM Patient Foundation, based on surveys, in-depth interviews and focus groups in 11 countries.
Austria’s Democracy Index Sinks for 4th Straight Year to 54.1 Percent
MENAFN
(MENAFN) Austria’s democratic health has slipped for a fourth year running, with a coalition of 10 non-governmental organizations warning Tuesday that the country’s score now sits just above its lowest point on record.
Boehringer Ingelheim and Microsoft partner to drive patient-centric and AI-backed clinical development
GlobeNewswire, Inc.
Two strong partners aim to accelerate AI-enabled clinical development Building a foundation for Digital Patient Twins to bring safe and effective therapies to patients sooner Potential co-development of projects in Animal Health and business...
KBR Awarded Contracts for AGF Nitrogen’s Ammonia Plant Revamps in Germany and Austria
GlobeNewswire, Inc.
HOUSTON, Oct. 22, 2026 (GLOBE NEWSWIRE) -- KBR (NYSE: KBR) announced today it has been awarded contracts to support the revamp of two ammonia plants owned and operated by AGF Nitrogen through its affiliated companies SKWP in Germany and LAT...
New Research Indicates Shared Roots of Major Neurodegenerative Diseases
EIN Presswire
Alzheimer’s, Parkinson’s, Macular Degeneration, and MS Share a Common Thread.
UEG Week: Teva and Sanofi’s Duvakitug Maintained Long-Term Positive Outcomes in New Phase 2b Data for Ulcerative Colitis and Crohn’s Disease
GlobeNewswire, Inc.
In UC, duvakitug maintained high rates of clinical remission, clinical response, and endoscopic improvement at Week 44 In CD, duvakitug maintained high rates of endoscopic response, clinical response, and clinical remission at Week 44 Duvakitug...
Moon World Resorts selects Smith + Andersen to Engineer Integrated, Sustainable Systems for MOON Smart Cities
EIN Presswire
Moon World Resorts Inc. has appointed Smith + Andersen, one of Canada’s largest privately owned integrated engineering firms for all MOON Smart City projects.
invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journal
GlobeNewswire, Inc.
invIOs publishes positive clinical data on CBL-B-silenced autologous cell therapy APN401 in peer-reviewed journal Publication in Molecular Therapy Oncology reports Phase 1 data from 17 patients with advanced, treatment-refractory solid tumors...
INNIO Reports Record Third Quarter 2026 Financial Results with Revenue Up 57%, Net Income Up 176% and Adjusted EBITDA Up 70%; Raises 2026 Full-Year Guidance
GlobeNewswire, Inc.
Third Quarter 2026 Financial Highlights Record Revenue: $1.2 billion, up 57% year-over-year, marking the first $1 billion-plus revenue quarter in INNIO’s history Equipment Growth: Equipment revenue increased 86% year-over-year to $777.6 million,...
NovaVia Health Highlights Overlooked Connection Between ADHD and Restless Legs Syndrome in Women
EIN Presswire
New educational resource explores how nighttime discomfort, disrupted sleep and overlapping symptoms can complicate ADHD care VIENNA, VA, UNITED STATES, October 13, 2026 /EINPresswire.com/ -- Women experiencing persistent fatigue, difficulty...
Austria's Deadly Summer: 995 Heat Deaths Set Grim Record
MENAFN
(MENAFN) An estimated 995 people died of heat-related causes in Austria from June to August 2026, the most since tracking began in 2017, the Austrian Agency for Health and Food Safety (AGES) said Friday.
Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical
GlobeNewswire, Inc.
Presentation of data from the INTEGUMENT-INFANT trial of investigational ZORYVE cream 0.05% in infants ages 3 to <24 months, where treatment options remain limited New analyses from the ARRECTOR and DERMIS-1/2 trials further demonstrate ZORYVE's...
Avaí Bio and Austrianova Hold First Joint Steering Committee Meeting with Ospedale San Raffaele for Diabetes Cell Therapy Program
GlobeNewswire, Inc.
LAS VEGAS, NEVADA, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”) and its joint venture partner Austrianova, today announced the first joint steering committee meeting for their collaboration with Ospedale...
AAVantgarde Presents Encouraging Clinical Data from AAVB-081 and Preclinical Data Supporting AAVB-039 at EURetina 2026
GlobeNewswire, Inc.
MILAN, Oct. 04, 2026 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), the clinical-stage biotechnology company developing genetic medicines for inherited retinal diseases (IRDs) using its proprietary dual-AAV technology, has today announced the...
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
GlobeNewswire, Inc.
SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio®” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have...
Navigator Medicines Presents New Data at EADV 2026 as Bispecific Antibody Program Advances at Speed in Hidradenitis Suppurativa
GlobeNewswire, Inc.
Phase 2a MAINSAIL Trial of NAV-240 in Hidradenitis Suppurativa (HS) Recruiting Ahead of Schedule Early Cohorts in Phase 1 Study of Next-Generation Subcutaneous Bispecific Antibody NAV-242 Indicate Extended Half Life (HLE) on Path to Goal of...
Avaí Bio and Austrianova Successfully Encapsulate GMP-Quality Klotho-Producing Cells, Achieve Robust Klotho Secretion
GlobeNewswire, Inc.
LAS VEGAS, NEVADA, Sept. 30, 2026 (GLOBE NEWSWIRE) -- Avaí Bio, Inc. (OTCQB: AVAI) (“Avaí” or the “Company”), an emerging biotech developing transformative cell-based therapies for diabetes, age-related disorders, and anti-aging, together with its...
CJ Biomaterials Secures BPI, TÜV AUSTRIA Certifications for New PHACT™ All-PHA Compound Designed for Home Compostable Cutlery
GlobeNewswire, Inc.
PHACT™ CB0104A earned BPI Commercial and Home Compostable, TÜV AUSTRIA OK compost HOME & OK compost INDUSTRIAL Certifications New all-PHA compound is designed for cutlery, caps, enclosures, beauty packaging, and agriculture, and horticulture...
Sagimet Announces Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne Presented at EADV 2026
GlobeNewswire, Inc.
In the Phase 3 open-label extension clinical trial (OLE), patients with moderate to severe acne received denifanstat for up to 52 weeks, including prior placebo patients Denifanstat showed progressive and sustained improvements across all efficacy...
Egle Therapeutics Announces Positive Phase 1 Data for EGL-003, Showing Favorable Safety and Selective Treg Expansion in Healthy Volunteer Study
GlobeNewswire, Inc.
EGL-003, a selective IL-2 agonist, was well tolerated across all four dose cohorts.
Sign up for:
Austria Health Focus
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.